This topic contains a solution. Click here to go to the answer

Author Question: The above figure shows the isoquants for producing steel. Decreasing returns to scale are A) ... (Read 72 times)

xroflmao

  • Hero Member
  • *****
  • Posts: 515
The above figure shows the isoquants for producing steel. Decreasing returns to scale are
 
  A) present when producing more than 10,000 tons.
  B) present when producing more than 20,000 tons.
  C) present when producing more than 30,000 tons.
  D) never present.

Question 2

Describe the characteristics of an efficient contract between a principal and an agent.
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

karlss

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

B

Answer to Question 2

An efficient contract is efficient in production. The principal's and agent's combined value of the contract is maximized. An efficient contract is also efficient in risk bearing. The risk sharing is optimal so that a relatively less risk-averse person bears more of the risk.




xroflmao

  • Member
  • Posts: 515
Reply 2 on: Jul 1, 2018
Wow, this really help


tuate

  • Member
  • Posts: 332
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

Did you know?

Medication errors are three times higher among children and infants than with adults.

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library